Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-25-043621)

Filing Details

Accession Number:: 0001213900-25-043621
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-05-14 21:55:17
Reporting Period:: 2025-05-12

Filing Date:: 2025-05-14
Accepted Time:: 2025-05-14 21:55:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1841330	Pasithea Therapeutics Corp.	KTTA	Pharmaceutical Preparations (2834)	851591963

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1875240	Tiago Marques	1111 Lincoln Road, Suite 500 Miami Beach FL 33139	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-05-12	960	$0.83	40,001	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The Reporting Person previously held 960 shares of Common Stock of the Issuer in a foreign brokerage account that was recently wound down. As a result, the foreign broker automatically liquidated the Reportion Person's account on May 12, 2025 by selling the 960 shares of Common Stock of the Issuer on a non-discretionary basis.